Furthermore, UA, at concentrations of 160 and 320 μg/mL, could inhibit inflammatory responses via the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) and NF-κB signaling pathways, reducing the viability of breast cancer cells (44). This evidence concerns the gene AKT1 and breast carcinoma.